Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
August 2024
in “
Cosmetics
”
androgenetic alopecia single-nucleotide polymorphisms SNPs androgen metabolism prostaglandin pathways vasodilation pharmacogenetics minoxidil finasteride SRD5A2 gene 5-alpha-reductase inhibitors RNA interference RNAi small interfering RNAs siRNAs androgen receptors hair growth AGA Propecia Rogaine 5-AR inhibitors
Studysummary This review discusses genetic and pharmacogenetic insights, along with RNA interference technologies, for developing personalized therapies for androgenetic alopecia, yet presents no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on mdpi.com →